Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Low-dose Ketamine Infusions for Perioperative Pain Management in Patients Undergoing Laparoscopic Gastric Bypass


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03448068

Organisation Name: Mayo Clinic

Overal Status: Active, not recruiting

Start Date: April 16, 2018

Last Update: February 11, 2020

Lead Sponsor: Mayo Clinic

Brief Summary: Opioid medications such as morphine, hydrocodone and oxycodone are standard for treating pain after surgery, however there are disadvantages. Because of the way opioids work, gastric bypass patients may have an increased risk of having sedation or problems with breathing. In patients with sleep apnea, opioids may increase the risk of severe apnea.

Ketamine is an alternative pain medicine that can be used to treat pain after surgery and may have fewer effects on breathing. Using ketamine as part of the regimen may be a better choice for laparoscopic gastric bypass patients.

This study is being done to find out if intraoperative ketamine infusion combined with continuation for twenty-four hours post-surgery provides superior pain control and decreases post-operative opioid use versus standard non-ketamine therapy.

Conditions:
  • Laparoscopic Gastric Bypass Surgery
  • Ketamine


Total execution time in seconds: 0.19540691375732